MiPT

MiPT
Legal status
Legal status	AU: Unscheduled; CA: Unscheduled; DE: NpSG (Industrial and scientific use only); UK: Class A; US: Unscheduled;
Identifiers
	IUPAC name N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine;
CAS Number	96096-52-5;
PubChem CID	29935323;
ChemSpider	21106353 ;
UNII	JO3SCR302A;
ChEMBL	ChEMBL353728 ;
CompTox Dashboard (EPA)	DTXSID901024777 ;
Chemical and physical data
Formula	C14H20N2
Molar mass	216.328 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)N(C)CCc1c[nH]c2ccccc12;
	InChI InChI=1S/C14H20N2/c1-11(2)16(3)9-8-12-10-15-14-7-5-4-6-13(12)14/h4-7,10-11,15H,8-9H2,1-3H3 ; Key:KTQJVAJLJZIKKD-UHFFFAOYSA-N ;
	(verify)

N-methyl-N-isopropyltryptamine (MiPT) is a psychedelic tryptamine, closely related to DMT, DiPT and miprocin. It was first synthesized by David Repke in 1984^[1] and was subsequently evaluated and described in Alexander Shulgin's 1997 book TiHKAL.

^ Glennon RA, Jacyno JM, Young R, McKenney JD, Nelson D (January 1984). "Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines". Journal of Medicinal Chemistry. 27 (1): 41–45. doi:10.1021/jm00367a008. PMID 6581313.

[1] Glennon RA, Jacyno JM, Young R, McKenney JD, Nelson D (January 1984). "Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines". Journal of Medicinal Chemistry. 27 (1): 41–45. doi:10.1021/jm00367a008. PMID 6581313.

[1]